Literature DB >> 31408011

A Subgroup of Chronic Low Back Pain Patients With Central Sensitization.

Kosaku Aoyagi1, Jianghua He2, Andrea L Nicol3, Daniel J Clauw4, Patricia M Kluding1, Stephen Jernigan1, Neena K Sharma1.   

Abstract

BACKGROUND: Our knowledge of central sensitization (CS) in chronic low back pain (CLBP) is limited. 2011 fibromyalgia criteria and severity scales (2011 FM survey) have been used to determine FM positive as a surrogate of CS. The major features of CS including widespread hyperalgesia and dysfunction of the descending inhibitory pathways can be identified by pressure pain threshold (PPT) and conditioned pain modulation (CPM) tests. The purpose of the study was to examine neurophysiological characteristics and psychosocial symptoms in a subgroup of FM-positive CLBP compared with FM-negative CLBP patients.
METHODS: A total of 46 participants with CLBP and 22 pain-free controls completed outcome measures of the 2011 FM survey, PPT and CPM tests, and psychosocial questionnaires. Differences between FM-positive and FM-negative CLBP participants on these measures and correlations were analyzed.
RESULTS: The 2011 FM survey identified 22 (48%) participants with CLBP as FM positive. FM-positive CLBP participants showed lower PPT values of the thumbnail (P=0.011) and lower back (P=0.003), lower CPM values of the thumbnail (P=0.002), and more severe pain catastrophizing, anxiety, and depression symptoms (P<0.05) than FM-negative CLBP participants. The 2011 FM scores were significantly correlated with the PPT and CPM values of the thumbnail and with psychosocial symptoms (P<0.001). DISCUSSION: Our findings suggest a subgroup of CLBP patients exhibiting with signs and symptoms of CS. Associations between subjective and objective CS measures indicate that the 2011 FM survey can be utilized to identify the presence of CS in CLBP in clinical practice.

Entities:  

Mesh:

Year:  2019        PMID: 31408011      PMCID: PMC7197191          DOI: 10.1097/AJP.0000000000000755

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  97 in total

1.  Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief.

Authors:  E Kosek; G Ordeberg
Journal:  Pain       Date:  2000-10       Impact factor: 6.961

2.  Prevalence of the fibromyalgia phenotype in patients with spine pain presenting to a tertiary care pain clinic and the potential treatment implications.

Authors:  Chad M Brummett; Jenna Goesling; Alex Tsodikov; Taha S Meraj; Ronald A Wasserman; Daniel J Clauw; Afton L Hassett
Journal:  Arthritis Rheum       Date:  2013-12

3.  Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition.

Authors:  Nancy Julien; Philippe Goffaux; Pierre Arsenault; Serge Marchand
Journal:  Pain       Date:  2005-03       Impact factor: 6.961

Review 4.  Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain.

Authors:  Jo Nijs; Adri Apeldoorn; Hank Hallegraeff; Jacqui Clark; Rob Smeets; Annaleen Malfliet; Enrique L Girbes; Margot De Kooning; Kelly Ickmans
Journal:  Pain Physician       Date:  2015 May-Jun       Impact factor: 4.965

5.  A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain.

Authors:  R Jason Giesbrecht; Michele C Battié
Journal:  Phys Ther       Date:  2005-10

6.  A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability.

Authors:  Gordon Waddell; Mary Newton; Iain Henderson; Douglas Somerville; Chris J Main
Journal:  Pain       Date:  1993-02       Impact factor: 6.961

7.  Outline of a Fear-Avoidance Model of exaggerated pain perception--I.

Authors:  J Lethem; P D Slade; J D Troup; G Bentley
Journal:  Behav Res Ther       Date:  1983

8.  Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain.

Authors:  Jo Nijs; Rafael Torres-Cueco; C Paul van Wilgen; Enrique Lluh Girbes; Filip Struyf; Nathalie Roussel; Jessica van Oosterwijck; Liesbeth Daenen; Kevin Kuppens; Luc Vanwerweeen; Linda Hermans; David Beckwee; Lennard Voogt; Jacqui Clark; Niamh Moloney; Mira Meeus
Journal:  Pain Physician       Date:  2014 Sep-Oct       Impact factor: 4.965

9.  Sex differences in the stability of conditioned pain modulation (CPM) among patients with chronic pain.

Authors:  Marc O Martel; Ajay D Wasan; Robert R Edwards
Journal:  Pain Med       Date:  2013-08-07       Impact factor: 3.750

10.  A novel paradigm to evaluate conditioned pain modulation in fibromyalgia.

Authors:  Cynthia J Schoen; Jacob N Ablin; Eric Ichesco; Rupal J Bhavsar; Laura Kochlefl; Richard E Harris; Daniel J Clauw; Richard H Gracely; Steven E Harte
Journal:  J Pain Res       Date:  2016-09-26       Impact factor: 3.133

View more
  15 in total

1.  Neurophysiological and transcriptomic predictors of chronic low back pain: Study protocol for a longitudinal inception cohort study.

Authors:  Angela Starkweather; Kathryn Ward; Bright Eze; Ahleah Gavin; Cynthia L Renn; Susan G Dorsey
Journal:  Res Nurs Health       Date:  2021-12-05       Impact factor: 2.228

2.  Adaptive body awareness predicts fewer central sensitization-related symptoms and explains relationship between central sensitization-related symptoms and pain intensity: A cross-sectional study among individuals with chronic pain.

Authors:  Dana Dharmakaya Colgan; Ashley Eddy; Kaylie Green; Barry Oken
Journal:  Pain Pract       Date:  2021-11-11       Impact factor: 3.183

3.  Translation and Cross-cultural Adaptation of the Fremantle Back Awareness Questionnaire into Persian language and the assessment of reliability and validity in patients with chronic low back pain.

Authors:  Ashraf Mahmoudzadeh; Sam Abbaszadeh; Hamzeh Baharlouei; Abdolkarim Karimi
Journal:  J Res Med Sci       Date:  2020-07-27       Impact factor: 1.852

4.  Pain inhibition is not affected by exercise-induced pain.

Authors:  Tibor M Szikszay; Waclaw M Adamczyk; Ewa Wojtyna; Kerstin Luedtke
Journal:  Pain Rep       Date:  2020-03-29

5.  Transcutaneous electrical nerve stimulation and heat to reduce pain in a chronic low back pain population: a randomized controlled clinical trial.

Authors:  Lynn Leemans; Ömer Elma; Jo Nijs; Timothy H Wideman; Carolie Siffain; Hester den Bandt; Sven Van Laere; David Beckwée
Journal:  Braz J Phys Ther       Date:  2020-05-12       Impact factor: 3.377

6.  Within-session test-retest reliability of pressure pain threshold and mechanical temporal summation in healthy subjects.

Authors:  Catherine Mailloux; Louis-David Beaulieu; Timothy H Wideman; Hugo Massé-Alarie
Journal:  PLoS One       Date:  2021-01-12       Impact factor: 3.240

7.  Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization.

Authors:  Tine van de Donk; Jurjan van Cosburgh; Tom van Dasselaar; Monique van Velzen; Asbjørn Mohr Drewes; Albert Dahan; Marieke Niesters
Journal:  Pain Rep       Date:  2020-12-17

8.  Female Overrepresentation in Low Back-Related Leg Pain: A Retrospective Study of the Autonomic Response to a Minimally Invasive Procedure.

Authors:  Elzbieta Skorupska; Marta Jokiel; Michał Rychlik; Rafał Łochowski; Małgorzata Kotwicka
Journal:  J Pain Res       Date:  2020-12-18       Impact factor: 3.133

Review 9.  The Definition, Assessment, and Prevalence of (Human Assumed) Central Sensitisation in Patients with Chronic Low Back Pain: A Systematic Review.

Authors:  Ingrid Schuttert; Hans Timmerman; Kristian K Petersen; Megan E McPhee; Lars Arendt-Nielsen; Michiel F Reneman; André P Wolff
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

10.  Diffuse central sensitization in low back patients: A secondary analysis of cross-sectional data including tender point examination and magnetic resonance imaging of the lumbar spine.

Authors:  Ole Kudsk Jensen; Claus Vinther Nielsen; Kristian Stengaard-Pedersen
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.